Recruiting at 1 site No phase Obsessive-Compulsive Disorder

Obsessive-Compulsive Disorder study: Psychoeducation

Official title Interpretation Bias as a Mechanism of Treatment Response in OCD

ClinicalTrials.gov ID: NCT05224414

What this study is testing

What it's testing
The study will see if CBM‑I is doable, acceptable, and if it helps people with OCD compared to a control training.
Who it's for
Adults who have been diagnosed with obsessive‑compulsive disorder and are receiving treatment.
What's involved
Participants will do up to 12 online CBM‑I sessions or 12 online psychoeducation sessions, while continuing their regular treatment.
Time commitment
The study lasts about 12 sessions, with each session done online at the participant’s convenience.
  • Which group you join is decided by chance.

A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.

Who can take part

Ages 18 and older

You may be able to join if

  • 1) OCD Institute patients
  • 2) adults (\> 18 years old)
  • 3) able to complete a computer task for 20 minutes
  • 4) consent to main OCD Institute study protocol
  • 5) primary diagnosis of OCD (as measured by a score of \>16 on the Y-BOCS and a clinical diagnosis of OCD by their treatment team

You likely can't join if

  • 1) Currently experiencing acute symptoms of psychosis
  • 2) Psychotic disorder diagnosis
See the full eligibility criteria
Who can join
  • 1) OCD Institute patients
  • 2) adults (\> 18 years old)
  • 3) able to complete a computer task for 20 minutes
  • 4) consent to main OCD Institute study protocol
  • 5) primary diagnosis of OCD (as measured by a score of \>16 on the Y-BOCS and a clinical diagnosis of OCD by their treatment team
  • 6) score of \>131 on the Obsessive Beliefs Questionnaire-44 at admission [which is 1 SD above the mean score of the non-clinical sample reported in the original validation paper by the Obsessive Compulsive Cognitions...
What rules you out
  • 1) Currently experiencing acute symptoms of psychosis
  • 2) Psychotic disorder diagnosis

The study team makes the final eligibility decision.

Where it is enrolling

  • Belmont, Massachusetts, United States

Questions & answers

Do participants get paid in this trial?

This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.

Is it free to join, and do I need insurance?

Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.

How long does this study last?

The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.

Who can join this trial?

This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.

Where is this trial taking place?

This study is enrolling now at Belmont, Massachusetts, United States. Enter your location above to see the nearest enrolling site and check your eligibility.

Explore other conditions

BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.